- Managerial Strategy for the Transportation and Transfusion Period for the Blood Components at Hospitals: An Opinion
-
Lee HR
- KMID: 2541999
- Korean J Blood Transfus.
- 2023 Apr;34(1):32-35.
- doi: 10.17945/kjbt.2023.34.1.3 2
For a safe and efficient blood transfusion, the transportation period of blood components from the blood bank to the patient and the transfusion period of blood components should be under... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of Malaria Antibody Test for Screening Blood Donors
-
Kang J, Kim J, Lee J, Ko DY, Kim HM, Choi KY
- KMID: 2541996
- Korean J Blood Transfus.
- 2023 Apr;34(1):21-25.
- doi: 10.17945/kjbt.2023.34.1.2 1
The Republic of Korea has been using malaria antibody assays to screen blood donors and reduce the risk of transfusion-transmitted malaria (TTM). This study examined the effectiveness of the current... -
- CITED
-
- Close
- SHARE
-
- Close
- An Overview of the Initiatives and Activities of the Korean Blood Safety Project Group over a Ten Year Period: 2012∼2021
-
Lim YA, Kim HO
- KMID: 2541994
- Korean J Blood Transfus.
- 2023 Apr;34(1):1-11.
- doi: 10.17945/kjbt.2023.34.1.1
Background: The study aimed to review the initiatives and activities of the Korean Blood Safety Project Group (KBSPG) from 2012 to 2021 to present its work domestically and internationally, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Considerations on ABO Genotyping Results: Lessons from ABO*AW.10 Allele Cases
-
Park DJ, Lim CS, Lim J
- KMID: 2542001
- Korean J Blood Transfus.
- 2023 Apr;34(1):39-42.
- doi: 10.17945/kjbt.2023.34.1.3 9
We would like to introduce domestic subscribers of the Korean Journal of Blood Transfusion to the important aspects to be considered while selecting a reference allele and reporting a new... -
- CITED
-
- Close
- SHARE
-
- Close
- Increasing the Number of Panel Cells for Unexpected Antibody Screening: Is It Economically Worth It?
-
Kim H, Ko DH
- KMID: 2542000
- Korean J Blood Transfus.
- 2023 Apr;34(1):36-38.
- doi: 10.17945/kjbt.2023.34.1.3 6
The unexpected antibody screening test is one of the most important pretransfusion tests. The tests are usually performed using commercial cells, which in Asia may not include clinically important antigens.... -
- CITED
-
- Close
- SHARE
-
- Close
- Elimination of ALX148 Interference in Pretransfusion Testing by RBC Alloadsorption: Two Case Reports
-
- KMID: 2541998
- Korean J Blood Transfus.
- 2023 Apr;34(1):26-31.
- doi: 10.17945/kjbt.2023.34.1.2 6
The anti-CD47 monoclonal antibody, one of the immune checkpoint inhibitors, can interfere with pretransfusion testing by binding to the cluster of differentiation 47 (CD47) proteins expressed on the surface of... -
- CITED
-
- Close
- SHARE
-
- Close
- Elimination of ALX148 Interference in Pretransfusion Testing by RBC Alloadsorption: Two Case Reports
-
Kim K, Ko I, Huh J
- KMID: 2541997
- Korean J Blood Transfus.
- 2023 Apr;34(1):26-31.
- doi: 10.17945/kjbt.2023.34.1.2 6
The anti-CD47 monoclonal antibody, one of the immune checkpoint inhibitors, can interfere with pretransfusion testing by binding to the cluster of differentiation 47 (CD47) proteins expressed on the surface of... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Application of ABO Genotyping: 5-Year Experience from a Single Tertiary Care Center in Korea
-
Lee HW, Jeong IH, Seo JY, Jang JH, Cho D
- KMID: 2541995
- Korean J Blood Transfus.
- 2023 Apr;34(1):12-20.
- doi: 10.17945/kjbt.2023.34.1.1 2
Background: ABO genotyping is performed when the exact ABO blood type cannot be determined through serological testing. Conventionally, only exons 6 and 7 of the ABO gene have been analyzed,... -
- CITED
-
- Close
- SHARE
-
- Close
